CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Physical activity for women with breast cancer after adjuvant therapy
Authors
Ahmed
Anderson
+301 more
Azim
Backer
Ballard-Barbash
Banasik
Baruth
Basen-Engquist
Battaglini
Beasley
Beisecker
Benton
Blank
Bloom
Bluethmann
Bluethmann
Bourke
Bourke
Bovelli
Bower
Bower
Bradt
Bray
Brown
Brown
Brown
Brown
Buffart
Buffart
Burnham
Button
Cadmus
Cadmus Bertram
Cadmus-Bertram
Camoriano
Candy
Cantarero-Villanueva
Cantarero-Villanueva
Cantarero-Villanueva
Cantarero-Villanueva
Cantarero-Villanueva
Carayol
Carson
Carter
Casla
Caspersen
Cella
Cella
Cerulli
Chan
Cheema
Cheema
Cheema
Chiu
Cho
Chung
Cochran
Cohen
Cormie
Courneya
Courneya
Craft
Cramer
Cramp
Cramp
Cuesta-Vargas
Culos-Reed
Cunningham
D'Attilio
Daley
Daley
Daley
Daley
Damush
Danhauer
Demark
Demark-Wahnefried
DeNysschen
Derry
DerSimonian
Dieli-Conwright
Dimeo
Djuric
Do
Dobek
Dolan
Duijts
Duijts
Duijts
Eastell
Egger
Ergun
Eton
Eyigor
Fairey
Fairey
Fairey
Fernandez-Lao
Fernandez-Lao
Ferrer
Fillion
Fong
Fong
Galantino
Galiano-Castillo
Galvao
Gordon
Greenland
Guinan
Guyatt
Gómez
Hanna
Hatchett
Hayes
Hayes
Headley
Heim
Herrero
Higgins
Hojan
Holmes
Hsiao-Fang
Hsieh
Hunt-Shanks
Husebo
Hutnick
Ibfelt
Ibrahim
Ingram
Irwin
Irwin
Irwin
Irwin
Isabell
Janelsins
Jeffs
Jemal
Johansson
Johnsson
Jones
Jong
Kaltsatou
Keilani
Kiecolt-Glaser
Kilbreath
Kilbreath
Kilbreath
Kilgour
Kim
Kim
Knols
Knols
Kodama
Kovacic
Kriska
Kroenke
Lahart
Lahart
Lahmann
LaStayo
Latka
Lee
Lee
Ligibel
Ligibel
Ligibel
Littman
Loh
Lohrisch
Loudon
Loudon
Luoma
Luu
Lynch
Malicka
Mantel
Markes
Martin
Matthews
May
McAuley
McClure
McGuire
McKenzie
McNeely
McNeely
Mefferd
Mehnert
Meneses-Echavez
Mewes
Milne
Milne
Mishra
Mishra
Moadel
Moher
Murtezani
Musanti
Mustian
Mustian
Naraphong
Naumann
Naumann
Nelson
Nieman
Nikander
Nikander
Noble
Nuri
Oh
Ohira
Oldervoll
Ott
Ott
Pan
Paramanandam
Payne
Peppone
Peppone
Peppone
Pinto
Pinto
Pinto
Pinto
Pinto
Pinto
Pinto
Pinto
Pinto
Pinto
Portela
Puymbroeck
Rabin
Rabin
Rabin
Rahnama
Rogers
Rogers
Rogers
Rogers
Rogers
Rogers
Rogers
Rogers
Saarto
Saarto
Sandel
Schmidt
Schmitz
Schmitz
Schmitz
Schmitz
Schmitz
Schneider
Schwartz
Segal
Segar
Sherman
Shoemaker
Short
Short
Short
Spark
Speck
Speck
Speed-Andrews
Sprod
Sprod
Sprod
Stan
Stan
Stevinson
Szczepanska-Gieracha
Taleghani
Tang
Taso
Thorsen
Tidhar
Turner
Twiss
Ulger
Vallance
Vallance
Vallance
Vallance
Vallance
Vallance
Waltman
Weert
Winters-Stone
Winters-Stone
Winters-Stone
Winters-Stone
Winters-Stone
Winters-Stone
Wong
Wu
Yang
Yost
Yuen
Zeng
Zhu
Zimmer
Publication date
1 January 2018
Publisher
'Wiley'
Doi
Abstract
© 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Background: Women with a diagnosis of breast cancer may experience short- and long-term disease and treatment-related adverse physiological and psychosocial outcomes. These outcomes can negatively impact prognosis, health-related quality of life (HRQoL), and psychosocial and physical function. Physical activity may help to improve prognosis and may alleviate the adverse effects of adjuvant therapy. Objectives: To assess effects of physical activity interventions after adjuvant therapy for women with breast cancer. Search methods: We searched the Cochrane Breast Cancer Group (CBCG) Specialised Registry, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), the Physiotherapy Evidence Database (PEDro), SPORTDiscus, PsycINFO, ClinicalTrials.gov, and the World Health Organization (WHO) International Clinical Trials Registry Platform, on 18 September 2015. We also searched OpenGrey and Healthcare Management Information Consortium databases. Selection criteria: We searched for randomised and quasi-randomised trials comparing physical activity interventions versus control (e.g. usual or standard care, no physical activity, no exercise, attention control, placebo) after adjuvant therapy (i.e. after completion of chemotherapy and/or radiation therapy, but not hormone therapy) in women with breast cancer. Data collection and analysis: Two review authors independently selected studies, assessed risk of bias, and extracted data. We contacted trial authors to ask for additional information when needed. We calculated an overall effect size with 95% confidence intervals (CIs) for each outcome and used GRADE to assess the quality of evidence for the most important outcomes. Main results: We included 63 trials that randomised 5761 women to a physical activity intervention (n = 3239) or to a control (n = 2524). The duration of interventions ranged from 4 to 24 months, with most lasting 8 or 12 weeks (37 studies). Twenty-eight studies included aerobic exercise only, 21 involved aerobic exercise and resistance training, and seven used resistance training only. Thirty studies described the comparison group as usual or standard care, no intervention, or control. One-fifth of studies reported at least 20% intervention attrition and the average physical activity adherence was approximately 77%. No data were available on effects of physical activity on breast cancer-related and all-cause mortality, or on breast cancer recurrence. Analysis of immediately postintervention follow-up values and change from baseline to end of intervention scores revealed that physical activity interventions resulted in significant small-to-moderate improvements in HRQoL (standardised mean difference (SMD) 0.39, 95% CI 0.21 to 0.57, 22 studies, 1996 women; SMD 0.78, 95% CI 0.39 to 1.17, 14 studies, 1459 women, respectively; low-quality evidence), emotional function (SMD 0.21, 95% CI 0.10 to 0.32, 26 studies, 2102 women, moderate-quality evidence; SMD 0.31, 95% CI 0.09 to 0.53, 15 studies, 1579 women, respectively; low-quality evidence), perceived physical function (SMD 0.33, 95% CI 0.18 to 0.49, 25 studies, 2129 women; SMD 0.60, 95% CI 0.23 to 0.97, 13 studies, 1433 women, respectively; moderate-quality evidence), anxiety (SMD -0.57, 95% CI -0.95 to -0.19, 7 studies, 326 women; SMD -0.37, 95% CI -0.63 to -0.12, 4 studies, 235 women, respectively; low-quality evidence), and cardiorespiratory fitness (SMD 0.44, 95% CI 0.30 to 0.58, 23 studies, 1265 women, moderate-quality evidence; SMD 0.83, 95% CI 0.40 to 1.27, 9 studies, 863 women, respectively; very low-quality evidence). Investigators reported few minor adverse events. Small improvements in physical activity interventions were sustained for three months or longer postintervention in fatigue (SMD -0.43, 95% CI -0.60 to -0.26; SMD -0.47, 95% CI -0.84 to -0.11, respectively), cardiorespiratory fitness (SMD 0.36, 95% CI 0.03 to 0.69; SMD 0.42, 95% CI 0.05 to 0.79, respectively), and self-reported physical activity (SMD 0.44, 95% CI 0.17 to 0.72; SMD 0.51, 95% CI 0.08 to 0.93, respectively) for both follow-up values and change from baseline scores. However, evidence of heterogeneity across trials was due to variation in intervention components (i.e. mode, frequency, intensity, duration of intervention and sessions) and measures used to assess outcomes. All trials reviewed were at high risk of performance bias, and most were also at high risk of detection, attrition, and selection bias. In light of the aforementioned issues, we determined that the evidence was of very low, low, or moderate quality. Authors' conclusions: No conclusions regarding breast cancer-related and all-cause mortality or breast cancer recurrence were possible. However, physical activity interventions may have small-to-moderate beneficial effects on HRQoL, and on emotional or perceived physical and social function, anxiety, cardiorespiratory fitness, and self-reported and objectively measured physical activity. The positive results reported in the current review must be interpreted cautiously owing to very low-to-moderate quality of evidence, heterogeneity of interventions and outcome measures, imprecision of some estimates, and risk of bias in many trials. Future studies with low risk of bias are required to determine the optimal combination of physical activity modes, frequencies, intensities, and durations needed to improve specific outcomes among women who have undergone adjuvant therapy.Published versio
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Wolverhampton Intellectual Repository and E-theses
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:wlv.openrepository.com:243...
Last time updated on 31/05/2019
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1002%2F14651858.cd...
Last time updated on 26/05/2021